A Phase I study of LFB-R603, a Novel Anti-CD20 Antibody, in Patients with Relapsed Chronic Lymphocytic Leukemia.

Drug Category: Array
Conference Category: Array
Lead Author: Cartron G, Cazin B, et al.
Published Date: 07/12/2010
Download Link: /wp-content/uploads/2019/03/ASH2010Poster2447.pdf
Download Text: Download
Popup Confirmation?:
site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
astra-migrate-meta-layouts: set
Scroll to Top